مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,160
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

THE EFFICACY OF LAMOTRIGINE ADJUNCTIVE THERAPY IN LENNOX-GASTAUT SYNDROME

Pages

  187-190

Abstract

 Background: LENNOX-GASTAUT SYNDROME (LGS) is one of the intractable epilepsies of childhood causing morbidity in patients who suffer this type of epilepsy. In this study the efficacy of LAMOTRIGINE (LTG) in LGS has been evaluated in children referring to Mofid hospital between 1997-98.Materials and methods: For this clinical trial, eighteen 4-12 year old children were selected. All of whom were resistant to conventional anti epileptic drugs. They have used at least five different categories of antiepileptic drugs but experienced at least one attack per day. Dose of LTG and its titration was adjusted according to the dosage of other antiepileptic drugs. Efficacy of LAMOTRIGINE was judged upon reduction of seizure frequency after 3 months of drug consumption compared to previous 3 months. Meanwhile, drug safety was evaluated based upon effects reported by parent's, clinical findings and results of periodic laboratory test. Results: Sixty percent of the patients (9 of 15) had more than 50% reduction in seizure frequency. Rash was noted in 17% of the patients (3 of 18) which necessitated discontinuation of LTG. Besides skin eruption, no any abnormal findings were noted in clinical or laboratory parameters. Conclusion: The results of our study indicate that LAMOTRIGINE add-on-drug therapy is both effective and safe in patients who suffered LGS.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    BARZEGAR, M., TONEKABONI, H., & GHOFRANI, M.. (2003). THE EFFICACY OF LAMOTRIGINE ADJUNCTIVE THERAPY IN LENNOX-GASTAUT SYNDROME. RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH), 8(3 (33)), 187-190. SID. https://sid.ir/paper/18324/en

    Vancouver: Copy

    BARZEGAR M., TONEKABONI H., GHOFRANI M.. THE EFFICACY OF LAMOTRIGINE ADJUNCTIVE THERAPY IN LENNOX-GASTAUT SYNDROME. RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH)[Internet]. 2003;8(3 (33)):187-190. Available from: https://sid.ir/paper/18324/en

    IEEE: Copy

    M. BARZEGAR, H. TONEKABONI, and M. GHOFRANI, “THE EFFICACY OF LAMOTRIGINE ADJUNCTIVE THERAPY IN LENNOX-GASTAUT SYNDROME,” RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH), vol. 8, no. 3 (33), pp. 187–190, 2003, [Online]. Available: https://sid.ir/paper/18324/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    مرکز اطلاعات علمی SID
    strs
    دانشگاه امام حسین
    بنیاد ملی بازیهای رایانه ای
    کلید پژوه
    ایران سرچ
    ایران سرچ
    File Not Exists.
    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button